Cytokinetics | CYTK - Equity Capital And Reserves


Cytokinetics reported $-659.62M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 917.27M 94.89M Sep/2025
Amgen USD 8.66B 961M Dec/2025
Arca Biopharma USD 469M 17.79M Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
Brainstorm Cell Therapeutics USD -9.98M 2.29M Dec/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Capricor Therapeutics USD 305.79M 221.92M Dec/2025
Cytokinetics USD -659.62M 138.5M Dec/2025
Eisai JPY 889.64B 35.21B Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Exelixis USD 2.16B 619K Dec/2025
Geron USD 225.87M 22.83M Dec/2025
Halozyme Therapeutics USD 48.81M 455.1M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
Ligand Pharmaceuticals USD 1.02B 67.04M Dec/2025
Merck USD 51.85B 2.79B Sep/2025
Novartis USD 46.13B 1.38B Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 72.81B 1.1B Mar/2026